Psychiatry News

Topline results from the open-label RESTORE trial showed that chloral hydrate improved symptoms of severe insomnia at 14 days in patients for whom previous behavioral and pharmaceutical solutions have failed.

Healio has announced the 2024 honorees of its peer-to-peer recognition program, Healio Honors.

Higher doses of buprenorphine were associated with significantly lower rates of acute care utilization among adults with opioid use disorder compared with the FDA’s recommended dose, according to a study published in JAMA Network Open.

Patients with chronic pain showed greater support for several policies expanding access to cannabis compared with physicians, a research letter in JAMA Network Open showed.

Fatal and nonfatal drug overdoses experienced “unprecedented” decreases of 10% to 20% from last year, which could be due to factors like increased naloxone availability, according to researchers.

Selling a medical practice is a complex transaction that involves not only the assets of the practice itself but also implicates associated real estate.

SAN DIEGO — Improving depressive symptoms can reduce patients’ chronic pain, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

The CDC issued a warning to health care officials, clinicians and patients about a potential risk for overdose among people ordering counterfeit prescription medications from online pharmacies.

Obscured by the celebratory congratulations and profuse praise of the scientific advance marked by the FDA’s approval of KarXT, now branded Cobenfy, is the revealing and instructive story of how this novel therapeutic agent came to fruition.

A New York-based biotechnology company has received a $4 million grant from the NIH’s National Institute on Aging to advance a novel intranasal therapeutic to treat Alzheimer’s disease, according to a press release from the manufacturer.